151 related articles for article (PubMed ID: 38493179)
1. Identification and validation of IRF6 related to ovarian cancer and biological function and prognostic value.
Hong S; Fu N; Sang S; Ma X; Sun F; Zhang X
J Ovarian Res; 2024 Mar; 17(1):64. PubMed ID: 38493179
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
4. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategy.
Wei M; Bai X; Dong Q
Transl Cancer Res; 2022 Jun; 11(6):1630-1643. PubMed ID: 35836518
[TBL] [Abstract][Full Text] [Related]
6. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
Wu M; Sun Y; Wu J; Liu G
Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
[TBL] [Abstract][Full Text] [Related]
7. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.
Zuo L; Li X; Tan Y; Zhu H; Xiao M
J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317
[TBL] [Abstract][Full Text] [Related]
8. Role of the KRT7 Biomarker in Immune Infiltration and Paclitaxel Resistance in Ovarian.
Wang S; Li H; Li M; Liu X; Yu S; Huang H; Wang X
Altern Ther Health Med; 2023 Jul; 29(5):132-140. PubMed ID: 37023314
[TBL] [Abstract][Full Text] [Related]
9. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
[TBL] [Abstract][Full Text] [Related]
10. Validation of ESM1 Related to Ovarian Cancer and the Biological Function and Prognostic Significance.
Li YK; Zeng T; Guan Y; Liu J; Liao NC; Wang MJ; Chen KX; Luo XY; Chen CY; Quan FF; Wang J; Zhang QF; Zou J
Int J Biol Sci; 2023; 19(1):258-280. PubMed ID: 36594088
[No Abstract] [Full Text] [Related]
11. Identification of hub genes and compounds controlling ovarian cancer stem cell characteristics via stemness indices analysis.
Wang Z; Wu D; Xia Y; Yang B; Xu T
Ann Transl Med; 2021 Mar; 9(5):379. PubMed ID: 33842600
[TBL] [Abstract][Full Text] [Related]
12. Construction of novel mRNA-miRNA-lncRNA regulatory networks associated with prognosis of ovarian cancer.
Gao L; Li X; Nie X; Guo Q; Liu Q; Qi Y; Liu J; Lin B
J Cancer; 2020; 11(23):7057-7072. PubMed ID: 33123295
[No Abstract] [Full Text] [Related]
13. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive bioinformatics analysis confirms RBMS3 as the central candidate biological target for ovarian cancer.
Wang M; Fu X; Wang W; Zhang Y; Jiang Z; Gu Y; Chu M; Shao Y; Li S
Med Eng Phys; 2022 Dec; 110():103883. PubMed ID: 36075788
[TBL] [Abstract][Full Text] [Related]
15. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis.
Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761
[TBL] [Abstract][Full Text] [Related]
16. Exploring prognostic genes in ovarian cancer stage-related coexpression network modules.
Yang L; Jing J; Sun L; Yue Y
Medicine (Baltimore); 2018 Aug; 97(34):e11895. PubMed ID: 30142790
[TBL] [Abstract][Full Text] [Related]
17. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
Dong C; Yin F; Zhu D; Cai X; Chen C; Liu X
J Cell Biochem; 2020 Nov; 121(11):4470-4483. PubMed ID: 32030795
[TBL] [Abstract][Full Text] [Related]
18. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
[TBL] [Abstract][Full Text] [Related]
19. Construction of a novel prognostic-predicting model correlated to ovarian cancer.
Tang W; Li J; Chang X; Jia L; Tang Q; Wang Y; Zheng Y; Sun L; Feng Z
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32716025
[TBL] [Abstract][Full Text] [Related]
20. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]